{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:06:01Z","timestamp":1790712361414,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["RF1AG076124, R01AG055770, R01AG067063, R01AG054434, R21AG056518, and P30AG066530"],"award-info":[{"award-number":["RF1AG076124, R01AG055770, R01AG067063, R01AG054434, R21AG056518, and P30AG066530"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"DOI":"10.1186\/s13195-025-01795-7","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T08:50:13Z","timestamp":1752137413000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Increased cerebrospinal fluid and plasma apoE glycosylation is associated with reduced levels of Alzheimer\u2019s disease biomarkers"],"prefix":"10.1186","volume":"17","author":[{"given":"Dobrin","family":"Nedelkov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe E.","family":"Tsokolas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matheus Scarpatto","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Sible","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Duke","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilal E.","family":"Kerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Renteln","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy J.","family":"Mack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tharick A.","family":"Pascoal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein N.","family":"Yassine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Alzheimer\u2019s Disease Neuroimaging Initiative","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"issue":"Pt 4","key":"1795_CR1","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1046\/j.1469-1809.1999.6340301.x","volume":"63","author":"RM Corbo","year":"1999","unstructured":"Corbo RM, Scacchi R. Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a \u2018thrifty\u2019 allele? Ann Hum Genet. 1999;63(Pt 4):301\u201310.","journal-title":"Ann Hum Genet"},{"issue":"16","key":"1795_CR2","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","volume":"278","author":"LA Farrer","year":"1997","unstructured":"Farrer LA, et al. Effects of age, sex, and ethnicity on the association between Apolipoprotein E genotype and alzheimer disease. A meta-analysis. APOE and alzheimer disease Meta analysis consortium. JAMA. 1997;278(16):1349\u201356.","journal-title":"JAMA"},{"issue":"12","key":"1795_CR3","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1001\/jamaneurol.2023.3599","volume":"80","author":"ME Belloy","year":"2023","unstructured":"Belloy ME, et al. APOE genotype and alzheimer disease risk across age, sex, and population ancestry. JAMA Neurol. 2023;80(12):1284\u201394.","journal-title":"JAMA Neurol"},{"issue":"9","key":"1795_CR4","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/mp.2011.52","volume":"16","author":"E Genin","year":"2011","unstructured":"Genin E, et al. APOE and alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatry. 2011;16(9):903\u20137.","journal-title":"Mol Psychiatry"},{"issue":"3","key":"1795_CR5","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1046\/j.1471-4159.2000.0741008.x","volume":"74","author":"M Michikawa","year":"2000","unstructured":"Michikawa M, et al. Apolipoprotein E exhibits isoform-specific promotion of lipid efflux from astrocytes and neurons in culture. J Neurochem. 2000;74(3):1008\u201316.","journal-title":"J Neurochem"},{"issue":"89","key":"1795_CR6","doi-asserted-by":"publisher","first-page":"89ra57","DOI":"10.1126\/scitranslmed.3002156","volume":"3","author":"JM Castellano","year":"2011","unstructured":"Castellano JM, et al. Human ApoE isoforms differentially regulate brain amyloid-\u03b2 peptide clearance. Sci Transl Med. 2011;3(89):89ra57.","journal-title":"Sci Transl Med"},{"issue":"9","key":"1795_CR7","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/iub.1314","volume":"66","author":"MC Phillips","year":"2014","unstructured":"Phillips MC. Apolipoprotein E isoforms and lipoprotein metabolism. IUBMB Life. 2014;66(9):616\u201323.","journal-title":"IUBMB Life"},{"issue":"8","key":"1795_CR8","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1194\/jlr.M500114-JLR200","volume":"46","author":"J Ruiz","year":"2005","unstructured":"Ruiz J, et al. The ApoE isoform binding properties of the VLDL receptor reveal marked differences from LRP and the LDL receptor. J Lipid Res. 2005;46(8):1721\u201331.","journal-title":"J Lipid Res"},{"issue":"51","key":"1795_CR9","doi-asserted-by":"publisher","first-page":"10881","DOI":"10.1021\/bi1017655","volume":"49","author":"D Nguyen","year":"2010","unstructured":"Nguyen D, et al. Molecular basis for the differences in lipid and lipoprotein binding properties of human apolipoproteins E3 and E4. Biochemistry. 2010;49(51):10881\u20139.","journal-title":"Biochemistry"},{"issue":"Pt 2","key":"1795_CR10","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1042\/bj3480359","volume":"348","author":"T Tokuda","year":"2000","unstructured":"Tokuda T, et al. Lipidation of Apolipoprotein E influences its isoform-specific interaction with alzheimer\u2019s amyloid beta peptides. Biochem J. 2000;348(Pt 2):359\u201365.","journal-title":"Biochem J"},{"issue":"21","key":"1795_CR11","doi-asserted-by":"publisher","first-page":"6771","DOI":"10.1523\/JNEUROSCI.0887-09.2009","volume":"29","author":"KR Bales","year":"2009","unstructured":"Bales KR, et al. Human APOE isoform-dependent effects on brain beta-amyloid levels in PDAPP Transgenic mice. J Neurosci. 2009;29(21):6771\u20139.","journal-title":"J Neurosci"},{"issue":"5","key":"1795_CR12","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s00109-018-1632-y","volume":"96","author":"M Kockx","year":"2018","unstructured":"Kockx M, Traini M, Kritharides L. Cell-specific production, secretion, and function of Apolipoprotein E. J Mol Med (Berl). 2018;96(5):361\u201371.","journal-title":"J Mol Med (Berl)"},{"issue":"15","key":"1795_CR13","doi-asserted-by":"publisher","first-page":"9094","DOI":"10.1016\/S0021-9258(18)81907-X","volume":"264","author":"ME Wernette-Hammond","year":"1989","unstructured":"Wernette-Hammond ME, et al. Glycosylation of human Apolipoprotein E. The carbohydrate attachment site is threonine 194. J Biol Chem. 1989;264(15):9094\u2013101.","journal-title":"J Biol Chem"},{"issue":"9","key":"1795_CR14","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1074\/mcp.M900430-MCP200","volume":"9","author":"Y Lee","year":"2010","unstructured":"Lee Y, et al. Glycosylation and sialylation of macrophage-derived human Apolipoprotein E analyzed by SDS-PAGE and mass spectrometry: evidence for a novel site of glycosylation on Ser290. Mol Cell Proteom. 2010;9(9):1968\u201381.","journal-title":"Mol Cell Proteom"},{"issue":"11","key":"1795_CR15","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/nmeth.1392","volume":"6","author":"J Nilsson","year":"2009","unstructured":"Nilsson J, et al. Enrichment of glycopeptides for glycan structure and attachment site identification. Nat Methods. 2009;6(11):809\u201311.","journal-title":"Nat Methods"},{"issue":"2","key":"1795_CR16","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1021\/pr300963h","volume":"12","author":"A Halim","year":"2013","unstructured":"Halim A, et al. LC-MS\/MS characterization of O-glycosylation sites and glycan structures of human cerebrospinal fluid glycoproteins. J Proteome Res. 2013;12(2):573\u201384.","journal-title":"J Proteome Res"},{"key":"1795_CR17","doi-asserted-by":"crossref","unstructured":"Flowers SA et al. O-glycosylation on cerebrospinal fluid and plasma Apolipoprotein E differs in the lipid binding domain. Glycobiology, 2019.","DOI":"10.1093\/glycob\/cwz084"},{"issue":"11","key":"1795_CR18","doi-asserted-by":"publisher","first-page":"3977","DOI":"10.1021\/acs.jproteome.9b00450","volume":"18","author":"C Zhu","year":"2019","unstructured":"Zhu C, et al. Site-Specific glycoprofiles of HDL-Associated ApoE are correlated with HDL functional capacity and unaffected by Short-Term diet. J Proteome Res. 2019;18(11):3977\u201384.","journal-title":"J Proteome Res"},{"issue":"6","key":"1795_CR19","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1111\/j.1471-4159.2010.06586.x","volume":"112","author":"CC Chua","year":"2010","unstructured":"Chua CC, Lim ML, Wong BS. Altered Apolipoprotein E glycosylation is associated with Abeta(42) accumulation in an animal model of Niemann-Pick type C disease. J Neurochem. 2010;112(6):1619\u201326.","journal-title":"J Neurochem"},{"issue":"1\u20132","key":"1795_CR20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.cca.2007.10.024","volume":"388","author":"M Sugano","year":"2008","unstructured":"Sugano M, et al. Sialic acid moiety of Apolipoprotein E3 at Thr(194) affects its interaction with beta-amyloid(1\u201342) peptides. Clin Chim Acta. 2008;388(1\u20132):123\u20139.","journal-title":"Clin Chim Acta"},{"issue":"9","key":"1795_CR21","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/S0026-0495(99)90136-1","volume":"48","author":"P Marmillot","year":"1999","unstructured":"Marmillot P, et al. Desialylation of human Apolipoprotein E decreases its binding to human high-density lipoprotein and its ability to deliver esterified cholesterol to the liver. Metabolism. 1999;48(9):1184\u201392.","journal-title":"Metabolism"},{"issue":"1\u20132","key":"1795_CR22","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cca.2008.12.018","volume":"402","author":"K Kawasaki","year":"2009","unstructured":"Kawasaki K, et al. Sialic acid moiety of Apolipoprotein E and its impact on the formation of lipoprotein particles in human cerebrospinal fluid. Clin Chim Acta. 2009;402(1\u20132):61\u20136.","journal-title":"Clin Chim Acta"},{"issue":"29","key":"1795_CR23","doi-asserted-by":"publisher","first-page":"13415","DOI":"10.1016\/S0021-9258(18)67033-4","volume":"261","author":"VI Zannis","year":"1986","unstructured":"Zannis VI, vanderSpek J, Silverman D. Intracellular modifications of human Apolipoprotein E. J Biol Chem. 1986;261(29):13415\u201321.","journal-title":"J Biol Chem"},{"issue":"1","key":"1795_CR24","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/0005-2760(87)90295-5","volume":"917","author":"RE Pitas","year":"1987","unstructured":"Pitas RE, et al. Astrocytes synthesize Apolipoprotein E and metabolize Apolipoprotein E-containing lipoproteins. Biochim Biophys Acta. 1987;917(1):148\u201361.","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"1795_CR25","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1093\/clinchem\/45.9.1431","volume":"45","author":"K Yamauchi","year":"1999","unstructured":"Yamauchi K, et al. Characterization of Apolipoprotein E-containing lipoproteins in cerebrospinal fluid: effect of phenotype on the distribution of Apolipoprotein E. Clin Chem. 1999;45(9):1431\u20138.","journal-title":"Clin Chem"},{"key":"1795_CR26","doi-asserted-by":"publisher","first-page":"115156","DOI":"10.1016\/j.ab.2023.115156","volume":"672","author":"PE Lawler","year":"2023","unstructured":"Lawler PE, et al. Apolipoprotein E O-glycosylation is associated with amyloid plaques and APOE genotype. Anal Biochem. 2023;672:115156.","journal-title":"Anal Biochem"},{"issue":"3","key":"1795_CR27","doi-asserted-by":"publisher","first-page":"883","DOI":"10.3233\/JAD-200203","volume":"76","author":"Y Hu","year":"2020","unstructured":"Hu Y, et al. Simple and fast assay for Apolipoprotein E phenotyping and glycotyping: discovering Isoform-Specific glycosylation in plasma and cerebrospinal fluid. J Alzheimers Dis. 2020;76(3):883\u201393.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"1795_CR28","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13195-023-01239-0","volume":"15","author":"CJ Meuret","year":"2023","unstructured":"Meuret CJ, et al. An association of CSF Apolipoprotein E glycosylation and amyloid-beta 42 in individuals who carry the APOE4 allele. Alzheimers Res Ther. 2023;15(1):96.","journal-title":"Alzheimers Res Ther"},{"issue":"2","key":"1795_CR29","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1373\/clinchem.2004.039347","volume":"51","author":"A Olsson","year":"2005","unstructured":"Olsson A, et al. Simultaneous measurement of beta-amyloid(1\u201342), total Tau, and phosphorylated Tau (Thr181) in cerebrospinal fluid by the xMAP technology. Clin Chem. 2005;51(2):336\u201345.","journal-title":"Clin Chem"},{"issue":"4","key":"1795_CR30","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1007\/s11682-012-9186-z","volume":"6","author":"PK Crane","year":"2012","unstructured":"Crane PK, et al. Development and assessment of a composite score for memory in the alzheimer\u2019s disease neuroimaging initiative (ADNI). Brain Imaging Behav. 2012;6(4):502\u201316.","journal-title":"Brain Imaging Behav"},{"key":"1795_CR31","doi-asserted-by":"crossref","unstructured":"Tosun D, et al. Association of CSF \u03b1-synuclein seed amplification assay positivity with disease progression and cognitive decline: A longitudinal Alzheimer\u2019s Disease Neuroimaging Initiative study. Volume 20. Alzheimer\u2019s & Dementia; 2024. pp. 8444\u201360. 12.","DOI":"10.1002\/alz.14276"},{"key":"1795_CR32","doi-asserted-by":"publisher","first-page":"105631","DOI":"10.1016\/j.nbd.2022.105631","volume":"164","author":"HJ Moon","year":"2022","unstructured":"Moon HJ, Haroutunian V, Zhao L. Human Apolipoprotein E isoforms are differentially sialylated and the Sialic acid moiety in ApoE2 attenuates ApoE2-A\u03b2 interaction and A\u03b2 fibrillation. Neurobiol Dis. 2022;164:105631.","journal-title":"Neurobiol Dis"},{"issue":"23","key":"1795_CR33","doi-asserted-by":"publisher","first-page":"e202212636","DOI":"10.1002\/anie.202212636","volume":"62","author":"D Mah","year":"2023","unstructured":"Mah D, et al. Apolipoprotein\u2005E recognizes alzheimer\u2019s disease associated 3-O sulfation of Heparan sulfate. Angew Chem Int Ed Engl. 2023;62(23):e202212636.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"4","key":"1795_CR34","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1007\/s12031-021-01943-2","volume":"72","author":"L Song","year":"2022","unstructured":"Song L, et al. Heparan sulfate proteoglycans (HSPGs) serve as the mediator between monomeric Tau and its subsequent intracellular ERK1\/2 pathway activation. J Mol Neurosci. 2022;72(4):772\u201391.","journal-title":"J Mol Neurosci"},{"issue":"2","key":"1795_CR35","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.bbrc.2017.06.067","volume":"490","author":"YS Chun","year":"2017","unstructured":"Chun YS, Kwon OH, Chung S. O-GlcNAcylation of amyloid-\u03b2 precursor protein at threonine 576 residue regulates trafficking and processing. Biochem Biophys Res Commun. 2017;490(2):486\u201391.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"1795_CR36","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/jb\/mvw056","volume":"161","author":"K Akasaka-Manya","year":"2017","unstructured":"Akasaka-Manya K, et al. Excess APP O-glycosylation by GalNAc-T6 decreases A\u03b2 production. J Biochem. 2017;161(1):99\u2013111.","journal-title":"J Biochem"},{"issue":"12","key":"1795_CR37","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1016\/j.bbagen.2006.08.008","volume":"1760","author":"D Patel","year":"2006","unstructured":"Patel D, Henry J, Good T. Attenuation of beta-amyloid induced toxicity by Sialic acid-conjugated dendrimeric polymers. Biochim Biophys Acta. 2006;1760(12):1802\u20139.","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"1795_CR38","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1016\/j.bbagen.2012.04.018","volume":"1820","author":"D Dhavale","year":"2012","unstructured":"Dhavale D, Henry JE. Evaluation of Sialic acid-analogs for the Attenuation of amyloid-beta toxicity. Biochim Biophys Acta. 2012;1820(10):1475\u201380.","journal-title":"Biochim Biophys Acta"},{"issue":"17","key":"1795_CR39","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1042\/BCJ20170239","volume":"474","author":"W Nolan","year":"2017","unstructured":"Nolan W, McHale-Owen H, Bate C. Sialylated glycosylphosphatidylinositols suppress the production of toxic amyloid-\u0152\u2264 oligomers. Biochem J. 2017;474(17):3045\u201358.","journal-title":"Biochem J"},{"issue":"1","key":"1795_CR40","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s13195-022-01108-2","volume":"14","author":"MP Lennol","year":"2022","unstructured":"Lennol MP, et al. Apolipoprotein E imbalance in the cerebrospinal fluid of alzheimer\u2019s disease patients. Alzheimers Res Ther. 2022;14(1):161.","journal-title":"Alzheimers Res Ther"},{"issue":"4","key":"1795_CR41","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/jnc.12484","volume":"128","author":"S Liu","year":"2014","unstructured":"Liu S, et al. Blocking the Apolipoprotein e\/amyloid \u03b2 interaction in triple Transgenic mice ameliorates alzheimer\u2019s disease related amyloid \u03b2 and Tau pathology. J Neurochem. 2014;128(4):577\u201391.","journal-title":"J Neurochem"},{"issue":"10","key":"1795_CR42","doi-asserted-by":"publisher","first-page":"5977","DOI":"10.1038\/s41380-020-0688-6","volume":"26","author":"J Therriault","year":"2021","unstructured":"Therriault J, et al. APOE\u03b54 potentiates the relationship between amyloid-\u03b2 and Tau pathologies. Mol Psychiatry. 2021;26(10):5977\u201388.","journal-title":"Mol Psychiatry"},{"issue":"2","key":"1795_CR43","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1006\/exnr.1996.0064","volume":"138","author":"LM Fleming","year":"1996","unstructured":"Fleming LM, et al. Differential binding of Apolipoprotein E isoforms to Tau and other cytoskeletal proteins. Exp Neurol. 1996;138(2):252\u201360.","journal-title":"Exp Neurol"},{"key":"1795_CR44","doi-asserted-by":"publisher","first-page":"100715","DOI":"10.1016\/j.jbc.2021.100715","volume":"296","author":"JM Cooper","year":"2021","unstructured":"Cooper JM, et al. Regulation of Tau internalization, degradation, and seeding by LRP1 reveals multiple pathways for Tau catabolism. J Biol Chem. 2021;296:100715.","journal-title":"J Biol Chem"},{"issue":"5","key":"1795_CR45","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1194\/jlr.M300418-JLR200","volume":"45","author":"L Krimbou","year":"2004","unstructured":"Krimbou L, et al. Molecular interactions between ApoE and ABCA1: impact on ApoE lipidation. J Lipid Res. 2004;45(5):839\u201348.","journal-title":"J Lipid Res"},{"issue":"43","key":"1795_CR46","doi-asserted-by":"publisher","first-page":"26043","DOI":"10.1074\/jbc.M115.679043","volume":"290","author":"Y Atagi","year":"2015","unstructured":"Atagi Y, et al. Apolipoprotein E is a ligand for triggering receptor expressed on myeloid cells 2 (TREM2). J Biol Chem. 2015;290(43):26043\u201350.","journal-title":"J Biol Chem"},{"issue":"36","key":"1795_CR47","doi-asserted-by":"publisher","first-page":"14813","DOI":"10.1073\/pnas.1106420108","volume":"108","author":"J Chen","year":"2011","unstructured":"Chen J, Li Q, Wang J. Topology of human Apolipoprotein E3 uniquely regulates its diverse biological functions. Proc Natl Acad Sci U S A. 2011;108(36):14813\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5\u20136","key":"1795_CR48","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00702-022-02461-0","volume":"129","author":"GS Benson","year":"2022","unstructured":"Benson GS, et al. Don\u2019t forget about tau: the effects of ApoE4 genotype on alzheimer\u2019s disease cerebrospinal fluid biomarkers in subjects with mild cognitive impairment-data from the dementia competence network. J Neural Transm (Vienna). 2022;129(5\u20136):477\u201386.","journal-title":"J Neural Transm (Vienna)"},{"issue":"12","key":"1795_CR49","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1001\/jamaneurol.2023.4038","volume":"80","author":"A Steward","year":"2023","unstructured":"Steward A, et al. ApoE4 and Connectivity-Mediated spreading of Tau pathology at lower amyloid levels. JAMA Neurol. 2023;80(12):1295\u2013306.","journal-title":"JAMA Neurol"},{"issue":"10","key":"1795_CR50","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1038\/s43587-023-00490-2","volume":"3","author":"JP Ferrari-Souza","year":"2023","unstructured":"Ferrari-Souza JP, et al. APOE\u03b54 potentiates amyloid \u03b2 effects on longitudinal Tau pathology. Nat Aging. 2023;3(10):1210\u20138.","journal-title":"Nat Aging"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01795-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-025-01795-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01795-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T05:25:45Z","timestamp":1757222745000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-025-01795-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1795"],"URL":"https:\/\/doi.org\/10.1186\/s13195-025-01795-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.12.20.629619","asserted-by":"object"}]},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,10]]},"assertion":[{"value":"14 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained for all participants at each site and each site operated according to institutional review board (IRB)\u2013approved protocol.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical declaration and consent to participate"}},{"value":"All authors read and approved the final manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Informed consent was obtained in accordance with the Declaration of Helsinki.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Dobrin Nedelkov is the President of Isoformix. All other authors have no conflicts of interest to declare.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"151"}}